Table 8.
Eicosanoids [µg/mL] | 1 vs. 2 | 1 vs. 3 | 1 vs. 5 | 2 vs. 3 | 2 vs. 5 | 3 vs. 5 |
---|---|---|---|---|---|---|
Resolvin E1 | NS | NS | NS | NS | NS | NS |
Prostaglandin E2 | NS | NS | NS | NS | NS | NS |
Resolvin D1 | NS | NS | NS | NS | NS | NS |
Lipoxin A4 LxA4 5S, 6R | NS | NS | NS | NS | NS | NS |
Lipoxin A4 15-epi-LxA4 A4 5S, 6R, 15R | NS | NS | NS | NS | 0.028 | 0.011 |
Protectin D1 | NS | NS | NS | NS | NS | NS |
Maresin 1 | 0.019 | NS | NS | NS | NS | NS |
Leucotriene B4 | NS | 0.037 | NS | NS | NS | NS |
18RS HEPE | NS | NS | NS | NS | NS | NS |
16RS HETE | NS | NS | NS | NS | NS | NS |
13S HODE | NS | NS | NS | NS | NS | NS |
9S HODE | NS | NS | NS | NS | NS | NS |
15S HETE | 0.011 | NS | NS | NS | NS | NS |
17RS HDHA | NS | NS | NS | NS | NS | NS |
12S HETE | NS | NS | NS | NS | NS | NS |
5-oxo-ETE | NS | NS | 0.045 | NS | NS | NS |
5 HETE NS | NS | NS | NS | NS | NS | NS |
NS statistically non-significant differences, p < 0.05 statistically significant differences, TOAST classification: 1 large-artery atherosclerosis, 2 cardioembolism, 3 small vessel occlusion (lacunar), 5 undetermined cause.